177 related articles for article (PubMed ID: 34997070)
1. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the
Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
[TBL] [Abstract][Full Text] [Related]
3. SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Eytan DF; Snow GE; Carlson S; Derakhshan A; Saleh A; Schiltz S; Cheng H; Mohan S; Cornelius S; Coupar J; Sowers AL; Hernandez L; Mitchell JB; Annunziata CM; Chen Z; Van Waes C
Cancer Res; 2016 Sep; 76(18):5442-5454. PubMed ID: 27469115
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells.
Thorne A; Bansal A; Necker-Brown A; Mostafa MM; Gao A; Georgescu A; Kooi C; Leigh R; Newton R
PLoS One; 2023; 18(6):e0286783. PubMed ID: 37289679
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of
Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
[TBL] [Abstract][Full Text] [Related]
6. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource.
Nguyen HT; Tang W; Webster ALH; Whiteaker JR; Chandler CM; Errazquin R; Roohollahi K; Fritzke M; Hoskins EE; Jonlin E; Wakefield L; Sullivan LB; Chen EY; Dorsman J; Brakenhoff R; Paulovich AG; Grompe M; Garcia-Escudero R; Wells SI; Smogorzewska A; Monnat RJ
Int J Cancer; 2023 Jul; 153(1):183-196. PubMed ID: 36912284
[TBL] [Abstract][Full Text] [Related]
8. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
Ma O; Cai WW; Zender L; Dayaram T; Shen J; Herron AJ; Lowe SW; Man TK; Lau CC; Donehower LA
Cancer Res; 2009 Mar; 69(6):2559-67. PubMed ID: 19276372
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.
Scheckenbach K; Wagenmann M; Freund M; Schipper J; Hanenberg H
Klin Padiatr; 2012 Apr; 224(3):132-8. PubMed ID: 22504776
[TBL] [Abstract][Full Text] [Related]
10. BIRC2 amplification in squamous cell carcinomas of the uterine cervix.
Choschzick M; Tabibzada AM; Gieseking F; Woelber L; Jaenicke F; Sauter G; Simon R
Virchows Arch; 2012 Aug; 461(2):123-8. PubMed ID: 22733500
[TBL] [Abstract][Full Text] [Related]
11. Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.
Tan BM; Zammit NW; Yam AO; Slattery R; Walters SN; Malle E; Grey ST
Diabetologia; 2013 Mar; 56(3):520-32. PubMed ID: 23250032
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma.
Pai G; Roohollahi K; Rockx D; de Jong Y; Stoepker C; Pennings C; Rooimans M; Vriend L; Piersma S; Jimenez CR; De Menezes RX; Van Beusechem VW; Brakenhoff RH; Te Riele H; Wolthuis RMF; Dorsman JC
Commun Biol; 2023 Jan; 6(1):37. PubMed ID: 36639418
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
[TBL] [Abstract][Full Text] [Related]
14. Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients.
Gammon L; Biddle A; Fazil B; Harper L; Mackenzie IC
J Oral Pathol Med; 2011 Feb; 40(2):143-52. PubMed ID: 21138479
[TBL] [Abstract][Full Text] [Related]
15. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
17. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
18. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
[TBL] [Abstract][Full Text] [Related]
19. Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.
Mudianto T; Campbell KM; Webb J; Zolkind P; Skidmore ZL; Riley R; Barnell EK; Ozgenc I; Giri T; Dunn GP; Adkins DR; Griffith M; Egloff AM; Griffith OL; Uppaluri R
Clin Cancer Res; 2021 Apr; 27(8):2326-2339. PubMed ID: 33547198
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential.
Yamato A; Soda M; Ueno T; Kojima S; Sonehara K; Kawazu M; Sai E; Yamashita Y; Nagase T; Mano H
Cancer Sci; 2015 Sep; 106(9):1137-42. PubMed ID: 26094954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]